Epizyme (EPZM) is a clinical-stage biotechnology pharmaceutical company that could get its first drug approval from the FDA in the near future.
I believe Epizyme is a strategic company for investors to acquire. Epigenetic therapies are likely to be major revenue and profit drivers in the coming century.
Why epigenetic therapies are strategic
Epigenetics refers to when traits of organisms are passed from parents to offspring, independent of the inherited DNA sequence. In other words, the cases where organisms have the same DNA, but do not manifest it in the same way. The